10/31/2013 - Pluripotent stem cell expert Hongkui Deng Joins ImStem's Scientific Advisory Board
8/23/2013 - The State's Connecticut Innovations Commits $150,000 to ImStem Biotechnology of Farmington
“ImStem's work is not only important from a public health standpoint, but is part of a wider growing biotech industry that is creating well-paying, high-tech jobs,” said Mike Demicco (D-Farmington).
Connecticut Innovation, the state’s quasi-public authority responsible for growing businesses has committed funding totaling $150,000 through its Pre-Seed Fund to ImStem biotechnology startup venture.
ImStem Biotechnology Inc. is an emerging biotechnology company developing cell therapeutic products derived from human embryonic stem cells for use in tissue repair and treatment of neural, heart, vascular and blood system and autoimmune diseases.
|
(From left to right, Dr. Xiaofang Wang, Dr. Hongkui Deng, Dr. Ren-He Xu) |
About ImStem Biotechnology, Inc.
ImStem is a biotechnology company developing therapies and stem cell product for tissue repair and autoimmune diseases. For more information about ImStem, visit www.imstem.com.
CONTACT:
Investor and Media Relations
860-281-STEM (7836)
admin@imstem.com
您可能喜欢
6/05/2014-ImStem Biotechnology, Inc. Makes Progress on Multiple Sclerosis Treatment with Embryonic Stem Cells
Farmington, Conn. - June 5, 2014. ImStem Biotechnology, Inc.(ImStem) announced t..
8/23/2013 - The State's Connecticut Innovations Commits $150,000 to ImStem Biotechnology of Farmington
8/23/2013 - The State's Connecticut ..
6/10/2013 -ImStem won 1.1 million stem cell research grant from State of Connecticut
IImStem won 1.1 million stem cell research grant from State of ConnecticutNine s..
2/18/2013 - New Stem Cell Company Opens Lab at UConn Health Center
A new stem cell company, ImStem Biotechnology Inc., is the latest research ventu..
T-MSC granted the patent authorization of Japan and Australia
T-MSC granted the patent authorization of Japan and AustraliaThe core technology..
9/12/2017-ImStem, UConn Obtain U.S. Patent for Mesenchymal Stem Cell Technology to Treat MS, Other Diseases
The U.S. Patent and Trademark Office has issued a patent for human embryonic ste..